JP2023540679A5 - - Google Patents
Info
- Publication number
- JP2023540679A5 JP2023540679A5 JP2023505864A JP2023505864A JP2023540679A5 JP 2023540679 A5 JP2023540679 A5 JP 2023540679A5 JP 2023505864 A JP2023505864 A JP 2023505864A JP 2023505864 A JP2023505864 A JP 2023505864A JP 2023540679 A5 JP2023540679 A5 JP 2023540679A5
- Authority
- JP
- Japan
- Prior art keywords
- lys
- pro
- isoglu
- diacid
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025253353A JP2026048851A (ja) | 2020-07-28 | 2025-12-16 | コンジュゲートされたヘプシジン模倣物 |
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063057583P | 2020-07-28 | 2020-07-28 | |
| US202063057577P | 2020-07-28 | 2020-07-28 | |
| US202063057574P | 2020-07-28 | 2020-07-28 | |
| US202063057582P | 2020-07-28 | 2020-07-28 | |
| US63/057,577 | 2020-07-28 | ||
| US63/057,574 | 2020-07-28 | ||
| US63/057,582 | 2020-07-28 | ||
| US63/057,583 | 2020-07-28 | ||
| US202163169527P | 2021-04-01 | 2021-04-01 | |
| US202163169515P | 2021-04-01 | 2021-04-01 | |
| US202163169533P | 2021-04-01 | 2021-04-01 | |
| US63/169,533 | 2021-04-01 | ||
| US63/169,527 | 2021-04-01 | ||
| US63/169,515 | 2021-04-01 | ||
| PCT/US2021/043581 WO2022026631A1 (en) | 2020-07-28 | 2021-07-28 | Conjugated hepcidin mimetics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025253353A Division JP2026048851A (ja) | 2020-07-28 | 2025-12-16 | コンジュゲートされたヘプシジン模倣物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540679A JP2023540679A (ja) | 2023-09-26 |
| JP2023540679A5 true JP2023540679A5 (enExample) | 2024-08-06 |
Family
ID=80036079
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505923A Pending JP2023536463A (ja) | 2020-07-28 | 2021-07-28 | コンジュゲート型ヘプシジン模倣体 |
| JP2023505864A Pending JP2023540679A (ja) | 2020-07-28 | 2021-07-28 | コンジュゲートされたヘプシジン模倣物 |
| JP2025186320A Pending JP2026012422A (ja) | 2020-07-28 | 2025-11-05 | コンジュゲート型ヘプシジン模倣体 |
| JP2025253353A Pending JP2026048851A (ja) | 2020-07-28 | 2025-12-16 | コンジュゲートされたヘプシジン模倣物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023505923A Pending JP2023536463A (ja) | 2020-07-28 | 2021-07-28 | コンジュゲート型ヘプシジン模倣体 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025186320A Pending JP2026012422A (ja) | 2020-07-28 | 2025-11-05 | コンジュゲート型ヘプシジン模倣体 |
| JP2025253353A Pending JP2026048851A (ja) | 2020-07-28 | 2025-12-16 | コンジュゲートされたヘプシジン模倣物 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20240066131A1 (enExample) |
| EP (2) | EP4188413A4 (enExample) |
| JP (4) | JP2023536463A (enExample) |
| KR (1) | KR20230053615A (enExample) |
| AU (2) | AU2021315564A1 (enExample) |
| CA (2) | CA3188410A1 (enExample) |
| IL (1) | IL299530A (enExample) |
| MX (1) | MX2023001292A (enExample) |
| PH (1) | PH12023500004A1 (enExample) |
| WO (3) | WO2022026631A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| HRP20211448T1 (hr) | 2014-05-16 | 2021-12-24 | Protagonist Therapeutics, Inc. | Alfa4beta7 integrin tioeter peptidni antagonisti |
| CN107206254B (zh) | 2014-07-17 | 2021-08-24 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| CA3089868A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| WO2020014646A1 (en) | 2018-07-12 | 2020-01-16 | Protagonist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CA3167751A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| JP7397239B2 (ja) | 2020-11-20 | 2023-12-12 | ヤンセン ファーマシューティカ エヌ．ベー． | インターロイキン－２３受容体のペプチド阻害剤の組成物 |
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| AU2022249095A1 (en) * | 2021-04-01 | 2023-10-12 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| US20240226225A1 (en) * | 2021-04-01 | 2024-07-11 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| EP4370146A4 (en) | 2021-07-14 | 2025-05-21 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of the interleukin-23 receptor |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| EP4472996A4 (en) * | 2022-02-02 | 2025-11-26 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
| EP4472995A4 (en) * | 2022-02-02 | 2025-11-19 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
| JP2025519535A (ja) * | 2022-06-07 | 2025-06-26 | プロタゴニスト セラピューティクス， インコーポレイテッド | 鎌状赤血球病の治療のためのヘプシジン模倣体 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5993811A (en) * | 1997-02-03 | 1999-11-30 | Biology Associates, Llc | Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| JP2003526634A (ja) * | 1999-12-03 | 2003-09-09 | ブリストル−マイヤーズ スクイブ ファーマ カンパニー | Ｃ型肝炎ウイルスＮＳ３プロテアーゼのα−ケトアミド阻害剤 |
| BR112014013697A2 (pt) * | 2011-12-09 | 2020-11-03 | The Regents Of The University Of California | peptídeos mini-hepcidina modificados e métodos de uso dos mesmos |
| EP4091624A1 (en) * | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| EP3129040A4 (en) * | 2014-04-07 | 2018-03-21 | La Jolla Pharmaceutical Company | Hepdicin mimetic peptides and uses thereof |
| WO2015200916A2 (en) * | 2014-06-27 | 2015-12-30 | Protagonist Therapeutics, Inc. | Hepcidin and mini-hepcidin analogues and uses therof |
| US20190002503A1 (en) * | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| WO2018128828A1 (en) * | 2016-12-23 | 2018-07-12 | Bayer Healthcare Llc | Novel hepcidin mimetics and uses thereof |
| CA3089868A1 (en) * | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
-
2021
- 2021-07-28 AU AU2021315564A patent/AU2021315564A1/en active Pending
- 2021-07-28 MX MX2023001292A patent/MX2023001292A/es unknown
- 2021-07-28 US US18/018,481 patent/US20240066131A1/en active Pending
- 2021-07-28 AU AU2021316000A patent/AU2021316000A1/en active Pending
- 2021-07-28 JP JP2023505923A patent/JP2023536463A/ja active Pending
- 2021-07-28 US US18/016,825 patent/US20230295259A1/en active Pending
- 2021-07-28 PH PH1/2023/500004A patent/PH12023500004A1/en unknown
- 2021-07-28 WO PCT/US2021/043581 patent/WO2022026631A1/en not_active Ceased
- 2021-07-28 EP EP21849116.5A patent/EP4188413A4/en active Pending
- 2021-07-28 JP JP2023505864A patent/JP2023540679A/ja active Pending
- 2021-07-28 WO PCT/US2021/043579 patent/WO2022026629A1/en not_active Ceased
- 2021-07-28 EP EP21848536.5A patent/EP4188412A4/en active Pending
- 2021-07-28 WO PCT/US2021/043584 patent/WO2022026633A1/en not_active Ceased
- 2021-07-28 KR KR1020237006472A patent/KR20230053615A/ko active Pending
- 2021-07-28 CA CA3188410A patent/CA3188410A1/en active Pending
- 2021-07-28 CA CA3189432A patent/CA3189432A1/en active Pending
- 2021-07-28 IL IL299530A patent/IL299530A/en unknown
- 2021-07-28 US US18/018,482 patent/US20240018189A1/en active Pending
-
2025
- 2025-11-05 JP JP2025186320A patent/JP2026012422A/ja active Pending
- 2025-12-16 JP JP2025253353A patent/JP2026048851A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540679A5 (enExample) | ||
| JP2023536463A5 (enExample) | ||
| US12269856B2 (en) | Hepcidin analogues and uses thereof | |
| JP2024513392A5 (enExample) | ||
| ES3058577T3 (en) | Conjugated hepcidin mimetics for use in treating of polycythemia vera | |
| JP2023540679A (ja) | コンジュゲートされたヘプシジン模倣物 | |
| JP2024513391A5 (enExample) | ||
| JP2012530145A5 (enExample) | ||
| WO2022212698A1 (en) | Conjugated hepcidin mimetics | |
| WO2022212696A1 (en) | Conjugated hepcidin mimetics | |
| CA3214153A1 (en) | Conjugated hepcidin mimetics | |
| EA053112B1 (ru) | Конъюгированные миметики гепсидина | |
| AR125266A1 (es) | Miméticos de hepcidina conjugados | |
| CN116457000A (zh) | 缀合的铁调素模拟物 | |
| CN117480176A (zh) | 用于治疗遗传性血色病的铁调素模拟物 | |
| HK1220112B (en) | Hepcidin analogues and uses therof |